(19)
(11) EP 3 517 105 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.06.2021 Bulletin 2021/25

(45) Mention of the grant of the patent:
28.04.2021 Bulletin 2021/17

(21) Application number: 19155852.7

(22) Date of filing: 19.07.2011
(51) International Patent Classification (IPC): 
A61K 9/70(2006.01)
 C09J 133/10(2006.01)

(54)

TRANSDERMAL ADHESIVE COMPOSITIONS, DEVICES, AND METHODS

TRANSDERMALE KLEBSTOFFZUSAMMENSETZUNGEN, VORRICHTUNGEN UND VERFAHREN

COMPOSITIONS ADHÉSIVES TRANSDERMIQUES, DISPOSITIFS ET PROCÉDÉS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 21.07.2010 US 36635810 P

(43) Date of publication of application:
31.07.2019 Bulletin 2019/31

(62) Application number of the earlier application in accordance with Art. 76 EPC:
11739245.6 / 2596071

(73) Proprietor: Kindeva Drug Delivery L.P.
St. Paul, MN 55170 (US)

(72) Inventors:
  • DIZIO,, James P.
    Saint Paul, MN Minnesota 55133-3427 (US)
  • JOHNSON,, Elizabeth E.
    Saint Paul, MN Minnesota 55133-3427 (US)
  • WU,, Zheng Zhi
    Saint Paul, MN Minnesota 55133-3427 (US)
  • PRESZLER PRINCE,, Amy
    Saint Paul, MN Minnesota 55133-3427 (US)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstrasse 3
81675 München
81675 München (DE)


(56) References cited: : 
WO-A2-01/30316
US-A1- 2002 119 187
 WO-A2-2005/049090
US-B1- 6 335 031
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).